Publications by authors named "Emil Samara"

Claim this Profile
A
A Phase I, Randomized, SAD, MAD, and PK Study of Risvodetinib in Older Adults and Parkinson's Disease.
Milton H Werner, C Warren Olanow, Andrew McGarry, Christopher Meyer, Sydney Kruger, Emil Samara

J Parkinsons Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of clinically relevant differences in safety and pharmacokinetics after second-dose administration of intranasal diazepam within 4 h for acute treatment of seizure clusters: A population analysis.
Gregory D Cascino, Daniel Tarquinio, James W Wheless, Robert Edward Hogan, Michael R Sperling, Emil Samara

Epilepsia· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BL-8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open-label safety and efficacy phase 2a study.
Gautam Borthakur, Yishai Ofran, Martin S Tallman, James Foran, Geoffrey L Uy, Emil Samara

Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Thorough QT/QTc Study With Laquinimod, a Novel Immunomodulator in Development for Multiple Sclerosis and Huntington Disease.
Ofer Spiegelstein, Dorit Mimrod, Laura Rabinovich, Eli Eyal, Craig Sprenger, Emil Samara

Clin Pharmacol Drug Dev· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and in vivo immune assessment of escalating doses of oral laquinimod in patients with RRMS.
Tjalf Ziemssen, Hayrettin Tumani, Tony Sehr, Katja Thomas, Friedemann Paul, Emil Samara

J Neuroinflammation· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis.
Barth L Wilsey, Reena Deutsch, Emil Samara, Thomas D Marcotte, Allan J Barnes

J Pain Res· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting pediatric age-matched weight and body mass index.
Sherwin K B Sy, Eduardo Asin-Prieto, Hartmut Derendorf, Emil Samara

AAPS J· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of dalfampridine extended release 7.5-mg tablets in healthy subjects and individuals with mild and moderate renal impairment: an open-label study.
Emil Samara, Peter Winkle, Patricia Pardo, Herbert R Henney, Susan L Way

J Clin Pharmacol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of telavancin in healthy subjects and patients with infections.
Emil Samara, Jeng-Pyng Shaw, Steven L Barriere, Shekman L Wong, Philip Worboys

Antimicrob Agents Chemother· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fostamatinib, a Syk-kinase inhibitor, does not affect methotrexate pharmacokinetics in patients with rheumatoid arthritis.
Muhammad Baluom, Emil Samara, Elliott B Grossbard, David T-W Lau

J Clin Pharmacol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-a-day extended-release dosage form of divalproex sodium III: development and validation of a Level A in vitro-in vivo correlation (IVIVC).
Sandeep Dutta, Yihong Qiu, Emil Samara, Guoliang Cao, G Richard Granneman

J Pharm Sci· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo target modulation and biological activity of CHIR-258, a multitargeted growth factor receptor kinase inhibitor, in colon cancer models.
Sang Hoon Lee, Daniel Lopes de Menezes, Jayesh Vora, Alex Harris, Helen Ye, Emil Samara

Clin Cancer Res· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis